189 related articles for article (PubMed ID: 17517829)
1. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.
Dickson SJ; Batson S; Copas AJ; Edwards SG; Singer M; Miller RF
Thorax; 2007 Nov; 62(11):964-8. PubMed ID: 17517829
[TBL] [Abstract][Full Text] [Related]
2. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy.
Adlakha A; Pavlou M; Walker DA; Copas AJ; Dufty N; Batson S; Edwards SG; Singer M; Miller RF
Int J STD AIDS; 2011 Sep; 22(9):498-504. PubMed ID: 21890545
[TBL] [Abstract][Full Text] [Related]
3. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
[TBL] [Abstract][Full Text] [Related]
4. The changing epidemiology of HIV-infected patients in the intensive care unit.
Akgün KM; Pisani M; Crothers K
J Intensive Care Med; 2011; 26(3):151-64. PubMed ID: 21436170
[TBL] [Abstract][Full Text] [Related]
5. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy.
Morris A; Creasman J; Turner J; Luce JM; Wachter RM; Huang L
Am J Respir Crit Care Med; 2002 Aug; 166(3):262-7. PubMed ID: 12153955
[TBL] [Abstract][Full Text] [Related]
6. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
[TBL] [Abstract][Full Text] [Related]
7. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.
Casalino E; Wolff M; Ravaud P; Choquet C; Bruneel F; Regnier B
AIDS; 2004 Jul; 18(10):1429-33. PubMed ID: 15199319
[TBL] [Abstract][Full Text] [Related]
8. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
Corona A; Raimondi F
Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.
Vincent B; Timsit JF; Auburtin M; Schortgen F; Bouadma L; Wolff M; Regnier B
Intensive Care Med; 2004 May; 30(5):859-66. PubMed ID: 14767592
[TBL] [Abstract][Full Text] [Related]
10. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
[TBL] [Abstract][Full Text] [Related]
11. Predictors of the short- and long-term survival of HIV-infected patients admitted to a Brazilian intensive care unit.
Amâncio FF; Lambertucci JR; Cota GF; Antunes CM
Int J STD AIDS; 2012 Oct; 23(10):692-7. PubMed ID: 23104742
[TBL] [Abstract][Full Text] [Related]
12. The long-term outcome of HIV-infected patients after intensive care admission.
Foo H; Clezy K; Post JJ
Int J STD AIDS; 2012 Jun; 23(6):e4-8. PubMed ID: 22807552
[TBL] [Abstract][Full Text] [Related]
13. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
14. Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors.
Chiang HH; Hung CC; Lee CM; Chen HY; Chen MY; Sheng WH; Hsieh SM; Sun HY; Ho CC; Yu CJ
Crit Care; 2011 Aug; 15(4):R202. PubMed ID: 21871086
[TBL] [Abstract][Full Text] [Related]
15. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.
Miller RF; Allen E; Copas A; Singer M; Edwards SG
Thorax; 2006 Aug; 61(8):716-21. PubMed ID: 16601092
[TBL] [Abstract][Full Text] [Related]
16. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
18. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
19. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
Jackson SR; Tweeddale MG; Barnett MJ; Spinelli JJ; Sutherland HJ; Reece DE; Klingemann HG; Nantel SH; Fung HC; Toze CL; Phillips GL; Shepherd JD
Bone Marrow Transplant; 1998 Apr; 21(7):697-704. PubMed ID: 9578310
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.
de Boer-van der Kolk IM; Sprangers MA; Prins JM; Smit C; de Wolf F; Nieuwkerk PT
Clin Infect Dis; 2010 Jan; 50(2):255-63. PubMed ID: 20014949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
